Skip to main content

CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.

Luk AWS, Ma Y, Ding PN, Young FP, Chua W, Balakrishnar B, Dransfield DT, Souza P, Becker TM

Publication: Int J Mol Sci (2017) • Vol 18PMID: 28498319View on PubMed

Purpose

This paper investigated effects of blood collection tube type and up to 48 h processing delay on the recovery of spiked-in prostate tumor cells in whole blood from healthy female participants. The effects of tube type, processing delay, and extended proteinase K treatment during RNA extraction on levels of androgen receptor variant 7 (AR-V7), total AR, and epithelial cell adhesion molecule (EpCAM) of spiked-in cells were also examined. The effect of delay to processing (24 or 48 h) on total AR, AR-V7, and EpCAM levels in circulating tumor cells (CTCs) isolated from EDTA blood of prostate cancer patients was also investigated.

Conclusion

Recovery of spiked-in cells was comparable for all tube types to that of the EDTA specimen with the exception of the RNA BCT specimen which had significantly higher cell recovery.  Cell recovery was significantly lower from blood processed after 24 and 30 h compared to blood processed immediately. Total AR, AR-V7, and EpCAM mRNA levels were similar in spiked-in cells from citrate blood to those from EDTA blood across all timepoints but levels were significantly lower in cells from all other tube types. Increased proteinase K digestion resulted in a decrease in measurable copy numbers of all three mRNA in cells recovered from EDTA and citrate tubes compared to the standard RNA extraction protocol but a small, statistically insignificant increase was observed in the detection of total AR and AR-V7 in cells from DNA BCT and RNA BCT, respectively when proteinase K digestion was extended. Total AR, AR-V7, and EpCAM mRNA levels varied widely in CTCs isolated from the three CRC patient blood specimens but were not significantly affected by a 24 or 48 h delay to processing.

Studies (2)

Purpose

This study investigated effects of blood collection tube type and up to 48 h processing delay on the recovery of spiked-in prostate tumor cells in whole blood from healthy female participants. The effects of tube type, processing delay, and extended proteinase K treatment during RNA extraction on levels of AR-V7, total AR, and EpCAM of spiked-in cells were also examined. Blood was collected from four healthy female participants into four K3EDTA, four ACD, four Streck Cell-free DNA BCT, four Streck Cell-free RNA BCT, and four Streck Cyto-Chex BCT; spiked with 100–200 cultured human prostate cancer cells, and stored at room temperature for 0, 24, 30, or 48 h. Peripheral blood mononuclear cells (PBMCs) were isolated using SepMate tubes and spiked-in EpCAM positive-cells were separated using immunomagnetic microbeads on an AutoMACS Pro Separator and then separated into two aliquots. One aliquot was kept on ice until enumeration with a CellCelector microscope and mean cell recovery numbers for each tube type were compared to the EDTA specimens. The other aliquot was centrifuged at 400 x g for 10 min and the pellet frozen at -80°C until RNA extraction using the Total RNA Purification Micro Kit. To examine the effects of extended proteinase K treatment, 38 mL blood from two healthy donors was drawn into one each of EDTA, Citrate, DNA BCT, and RNA BCT tubes; PBMCs were isolated after 48 h at room temperature; and then EpCAM positive-cells were separated using the process described above and frozen at -80°C until RNA extraction with or without an additional 2 h proteinase K treatment. cDNA was synthesized with the SensiFAST cDNA Synthesis Kit and gene expression levels of total AR, AR-V7, and EpCAM were measured by droplet digital PCR (ddPCR).

Summary of Findings

Mean recovery of spiked-in cells ranged from 13%-44% across all time points and tube types. Mean cell recovery was comparable for all tube types to that of the EDTA specimen with the exception of the RNA BCT specimen which had a higher recovery than EDTA at each time point (P<0.05). Cell recovery was significantly lower from blood processed after 24 and 30 h compared to blood processed immediately (P<0.05) but there was no significant difference between mean cell recovery at 0 and 48 h, which the authors attribute to the difficulties of spiking exact cell numbers due to a strong tendency of cell clustering. While total AR, AR-V7, and EpCAM mRNA levels from spiked-in cells from citrate blood were similar to those from EDTA blood, evaluated mRNA levels were significantly lower in cells from all other tube types compared to the EDTA specimens across all timepoints (P<0.01, all). Increased proteinase K digestion resulted in a decrease in measurable copy numbers of all three mRNAs in cells recovered from EDTA and citrate tubes compared to the standard RNA extraction protocol but a small, statistically insignificant increase in the detection of total AR and AR-V7 mRNA in cells from DNA BCT and RNA BCT, respectively.

  • Biospecimens

    CellWhite Cells
    FluidBlood
  • Preservation Types

    Other PreservativeStreck/BCT
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    Cell count/volumeFluorescent microscopy
    RNADigital PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    ACD tube
    EDTA tube
    Streck Cell-free DNA BCT
    Streck Cell-free RNA BCT
    Streck Cyto-Chex BCT
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageTime at room temperature
    0 h
    24 h
    30 h
    48 h
    Digital PCR SpecificTargeted nucleic acid
    AR-V7
    EpCAM
    Total AR